Long-term dissemination of acquired AmpC β-lactamases among Klebsiella spp. and Escherichia coli in Portuguese clinical settings

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 4, 2014, Pages 551-558

  Freitas, F ^a,b,c   Machado, E ^a,b   Ribeiro, T G ^a,b   Novais, A ^a   Peixe, L ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^c Centro Hospitalar Tondela Viseu   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BETA LACTAMASE; BETA LACTAMASE CTX M; BETA LACTAMASE OXA 1; BETA LACTAMASE SHV; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; GENTAMICIN; KANAMYCIN; NALIDIXIC ACID; NETILMICIN; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN; TRIMETHOPRIM; UNCLASSIFIED DRUG; AMPC BETA-LACTAMASES; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN;

ACQUIRED AMPC BETA LACTAMASE GENE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM CONJUGATION; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLA QAMPC GENE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; GENE SEQUENCE; GENETIC CODE; KLEBSIELLA; KLEBSIELLA OXYTOCA; MOLECULAR CLONING; MOLECULAR EPIDEMIOLOGY; NONHUMAN; POLYMERASE CHAIN REACTION; PORTUGAL; PRIORITY JOURNAL; DRUG EFFECTS; EPIDEMIOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENETICS; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; MEDICAL GEOGRAPHY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENES, BACTERIAL; GEOGRAPHY, MEDICAL; HOSPITALS; HUMANS; KLEBSIELLA; KLEBSIELLA INFECTIONS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; PORTUGAL;

EID: 84896975447     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-013-1983-9     Document Type: Article

References (53)

1. D'Andrea MM, Nucleo E, Luzzaro F, Giani T, Migliavacca R, Vailati F, Kroumova V, Pagani L, Rossolini GM (2006) CMY-16, a novel acquired AmpC-type β-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from Northern Italy. Antimicrob Agents Chemother 50(2):618-624 (Pubitemid 43190974)
2. Jacoby GA (2009) AmpC β-lactamases. Clin Microbiol Rev 22(1):161-182
3. Mata C, Miró E, Alvarado A, Garcillán-Barcia MP, Toleman M, Walsh TR, de la Cruz F, Navarro F (2012) Plasmid typing and genetic context of AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes: findings from a Spanish hospital 1999-2007. J Antimicrob Chemother 67(1):115-122
4. Miró E, Agüero J, Larrosa MN, Fernández A, Conejo MC, Bou G, González-López JJ, Lara N, Martínez-Martínez L, Oliver A, Aracil B, Oteo J, Pascual A, Rodríguez-Baño J, Zamorano L, Navarro F (2013) Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain. Eur J Clin Microbiol Infect Dis 32(2):253-259
5. Iabadene H, Messai Y, Ammari H, Alouache S, Verdet C, Bakour R, Arlet G (2009) Prevalence of plasmid-mediated AmpC β-lactamases among Enterobacteriaceae in Algiers hospitals. Int J Antimicrob Agents 34(4):340-342
6. Cejas D, Fernández Canigia L, Quinteros M, Giovanakis M, Vay C, Lascialandare S, Mutti D, Pagniez G, Almuzara M, Gutkind G, Radice M (2012) Plasmid-encoded AmpC (pAmpC) in Enterobacteriaceae: epidemiology of microorganisms and resistance markers. Rev Argent Microbiol 44(3):182-186
7. Simner PJ, Zhanel GG, Pitout J, Tailor F, McCracken M, Mulvey MR, Lagacé-Wiens PR, Adam HJ, Hoban DJ; Canadian Antimicrobial Resistance Alliance (CARA) (2011) Prevalence and characterization of extended-spectrum β-lactamase- and AmpC β-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study. Diagn Microbiol Infect Dis 69(3):326-334
8. Baudry PJ, Mataseje L, Zhanel GG, Hoban DJ, Mulvey MR (2009) Characterization of plasmids encoding CMY-2 AmpC β-lactamases from Escherichia coli in Canadian intensive care units. Diagn Microbiol Infect Dis 65(4):379-383
9. Li Y, Li Q, Du Y, Jiang X, Tang J, Wang J, Li G, Jiang Y (2008) Prevalence of plasmid-mediated AmpC β-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-type AmpC β-lactamase resistance in China. J Clin Microbiol 46(4):1317-1321 (Pubitemid 351563573)
10. Ding H, Yang Y, Lu Q, Wang Y, Chen Y, Deng L, Wang A, Deng Q, Zhang H, Wang C, Liu L, Xu X, Wang L, Shen X (2008) The prevalence of plasmid-mediated AmpC β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children's hospitals in China. Eur J Clin Microbiol Infect Dis 27(10):915-921
11. Jørgensen RL, Nielsen JB, Friis-Møller A, Fjeldsøe-Nielsen H, Schønning K (2010) Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype. J Antimicrob Chemother 65(3):460-464
12. Corvec S, Crémet L, Leprince C, Dauvergne S, Reynaud A, Lepelletier D, Caroff N (2010) Epidemiology of Escherichia coli clinical isolates producing AmpC plasmidic β-lactamase during a 5-year period in a French teaching Hospital. Diagn Microbiol Infect Dis 67(3):277-281
13. Matsumura Y, Yamamoto M, Higuchi T, Komori T, Tsuboi F, Hayashi A, Sugimoto Y, Hotta G, Matsushima A, Nagao M, Takakura S, Ichiyama S (2012) Prevalence of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and spread of the ST131 clone among extended-spectrum β-lactamase-producing E. coli in Japan. Int J Antimicrob Agents 40(2):158-162
14. Yamasaki K, Komatsu M, Abe N, Fukuda S, Miyamoto Y, Higuchi T, Ono T, Nishio H, Sueyoshi N, Kida K, Satoh K, Toyokawa M, Nishi I, Sakamoto M, Akagi M, Nakai I, Kofuku T, Orita T, Wada Y, Jikimoto T, Kinoshita S, Miyamoto K, Hirai I, Yamamoto Y (2010) Laboratory surveillance for prospective plasmid-mediated AmpC β-lactamases in the Kinki region of Japan. J Clin Microbiol 48(9):3267-3273
15. Song W, Kim JS, Kim HS, Yong D, Jeong SH, Park MJ, Lee KM (2006) Increasing trend in the prevalence of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean university hospital from 2002 to 2004. Diagn Microbiol Infect Dis 55(3):219-224 (Pubitemid 43928405)
16. Song W, Lee H, Lee K, Jeong SH, Bae IK, Kim JS, Kwak HS (2009) CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum β-lactamase in clinical isolates of Escherichia coli from Korea. J Med Microbiol 58(Pt 2):261-266
17. Voets GM, Platteel TN, Fluit AC, Scharringa J, Schapendonk CM, Stuart JC, Bonten MJ, Hall MA; National ESBL Surveillance Working Group (2012) Population distribution of beta-lactamase conferring resistance to third-generation cephalosporins in human clinical Enterobacteriaceae in the Netherlands. PLoS One 7(12):e52102
18. Naseer U, Haldorsen B, Simonsen GS, Sundsfjord A (2010) Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway. Clin Microbiol Infect 16(2):171-178
19. Mata C, Miró E, Rivera A, Mirelis B, Coll P, Navarro F (2010) Prevalence of acquired AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes at a Spanish hospital from 1999 to 2007. Clin Microbiol Infect 16(5):472-476
20. CMY-2 in Proteus mirabilis. J Antimicrob Chemother 66(10):2266-2270
21. Adler H, Fenner L, Walter P, Hohler D, Schultheiss E, Oezcan S, Frei R (2008) Plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes: prevalence at a Swiss university hospital and occurrence of the different molecular types in Switzerland. J Antimicrob Chemother 61(2):457-458
22. Singtohin S, Chanawong A, Lulitanond A, Sribenjalux P, Auncharoen A, Kaewkes W, Songsri J, Pienthaweechai K (2010) CMY-2, CMY-8b, and DHA-1 plasmid-mediated AmpC β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from a university hospital, Thailand. Diagn Microbiol Infect Dis 68(3):271-277
23. Deshpande LM, Jones RN, Fritsche TR, Sader HS (2006) Occurrence of plasmidic AmpC type β-lactamase-mediated resistance in Escherichia coli: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004). Int J Antimicrob Agents 28(6):578-581 (Pubitemid 44779181)
24. Alvarez M, Tran JH, Chow N, Jacoby GA (2004) Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States. Antimicrob Agents Chemother 48(2):533-537 (Pubitemid 38141713)
25. SHV-11 in a Belgian hospital, August-December 2006. Euro Surveill 12(5):pii=3110
26. Illiaquer M, Caroff N, Bémer P, Aubin GG, Juvin ME, Lepelletier D, Reynaud A, Corvec S (2012) Occurrence and molecular characterization of Klebsiella pneumoniae ST37 clinical isolates producing plasmid-mediated AmpC recovered over a 3-year period. Diagn Microbiol Infect Dis 74(1):95-97
27. Roche C, Boo TW, Walsh F, Crowley B (2008) Detection and molecular characterisation of plasmidic AmpC beta-lactamases in Klebsiella pneumoniae isolates from a tertiary-care hospital in Dublin, Ireland. Clin Microbiol Infect 14(6):616-618 (Pubitemid 351639081)
28. D'Andrea MM, Literacka E, Zioga A, Giani T, Baraniak A, Fiett J, Sadowy E, Tassios PT, Rossolini GM, Gniadkowski M, Miriagou V (2011) Evolution and spread of a multidrug-resistant Proteus mirabilis clone with chromosomal AmpC-type cephalosporinases in Europe. Antimicrob Agents Chemother 55(6):2735-2742
29. ACC-1 in Salmonella enterica serotype Livingstone causing a large nosocomial outbreak in Tunisia. Microb Drug Resist 15(4):279-286
30. Lee JH, Jung HI, Jung JH, Park JS, Ahn JB, Jeong SH, Jeong BC, Lee JH, Lee SH (2004) Dissemination of transferable AmpC-type beta-lactamase (CMY-10) in a Korean hospital. Microb Drug Resist 10(3):224-230 (Pubitemid 39281723)
31. Kim JY, Song JS, Bak SH, Cho YE, Kim DW, Jeong SH, Park YM, Lee KJ, Lee SH (2004) Dissemination of Escherichia coli producing AmpC-type beta-lactamase (CMY-11) in Korea. Int J Antimicrob Agents 24(4):320-326 (Pubitemid 39369475)
32. Machado E, Coque TM, Cantón R, Novais Â, Sousa JC, Baquero F, Peixe L; Portuguese Resistance Study Group (2007) High diversity of extended-spectrum β-lactamases among clinical isolates of Enterobacteriaceae from Portugal. J Antimicrob Chemother 60(6):1370-1374 (Pubitemid 350168335)
33. Mirelis B, Rivera A, Miró E, Mesa RJ, Navarro F, Coll P (2006) A simple phenotypic method for differentiation between acquired and chromosomal AmpC β-lactamases in Escherichia coli. Enferm Infecc Microbiol Clin 24(6):370-372 (Pubitemid 44133182)
34. Koeck JL, Arlet G, Philippon A, Basmaciogullari S, Thien HV, Buisson Y, Cavallo JD (1997) A plasmid-mediated CMY-2 β-lactamase from an Algerian clinical isolate of Salmonella senftenberg. FEMS Microbiol Lett 152(2):255-260 (Pubitemid 27305827)
35. Jarlier V, Nicolas MH, Fournier G, Philippon A (1988) Extended broad-spectrum β-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 10(4):867-878
36. Verdet C, Benzerara Y, Gautier V, Adam O, Ould-Hocine Z, Arlet G (2006) Emergence of DHA-1-producing Klebsiella spp. in the Parisian region: genetic organization of the ampC and ampR genes originating from Morganella morganii. Antimicrob Agents Chemother 50(2):607-617 (Pubitemid 43190973)
37. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33(9):2233-2239
38. Clermont O, Bonacorsi S, Bingen E (2000) Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66(10):4555-4558
39. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M (2010) Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 51(3):286-294
40. Song S, Lee EY, Koh EM, Ha HS, Jeong HJ, Bae IK, Jeong SH (2009) Antibiotic resistance mechanisms of Escherichia coli isolates from urinary specimens. Korean J Lab Med 29(1):17-24
41. Arpin C, Quentin C, Grobost F, Cambau E, Robert J, Dubois V, Coulange L, André C; Scientific Committee of ONERBA (2009) Nationwide survey of extended-spectrum β-lactamase-producing Enterobacteriaceae in the French community setting. J Antimicrob Chemother 63(6):1205-1214
42. Johnson JR, Stell AL (2000) Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 181(1):261-272 (Pubitemid 30049057)
43. Moreno E, Prats G, Planells I, Planes AM, Pérez T, Andreu A (2006) Characterization of Escherichia coli isolates derived from phylogenetic groups A and B1 causing extraintestinal infection. Enferm Infecc Microbiol Clin 24(8):483-489 (Pubitemid 44745486)
44. Cooke NM, Smith SG, Kelleher M, Rogers TR (2010) Major differences exist in frequencies of virulence factors and multidrug resistance between community and nosocomial Escherichia coli bloodstream isolates. J Clin Microbiol 48(4):1099-1104
45. Rodríguez-Baño J, Mingorance J, Fernández-Romero N, Serrano L, López-Cerero L, Pascual A; ESBL-REIPI Group (2012) Virulence profiles of bacteremic extended-spectrum β-lactamase-producing Escherichia coli: association with epidemiological and clinical features. PLoS One 7(9):e44238
46. Sidjabat HE, Paterson DL, Qureshi ZA, Adams-Haduch JM, O'Keefe A, Pascual A, Rodríguez-Baño J, Doi Y (2009) Clinical features and molecular epidemiology of CMY-type beta-lactamase-producing Escherichia coli. Clin Infect Dis 48(6):739-744
47. Cantón R, Novais Â, Valverde A, Machado E, Peixe L, Baquero F, Coque TM (2008) Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 14(Suppl 1):144-153 (Pubitemid 350269194)
48. Giamarellou H (2005) Multidrug resistance in Gram-negative bacteria that produce extended-spectrum beta-lactamases (ESBLs). Clin Microbiol Infect 11(Suppl 4):1-16
49. Mendonça N, Leitão J, Manageiro V, Ferreira E, Caniça M (2007) Spread of extended-spectrum beta-lactamase CTX-M-producing Escherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrob Agents Chemother 51(6):1946-1955
50. Machado E, Coque TM, Cantón R, Baquero F, Sousa JC, Peixe L; Portuguese Resistance Study Group (2006) Dissemination in Portugal of CTX-M-15-, OXA-1-, and TEM-1-producing Enterobacteriaceae strains containing the aac(6′)-Ib-cr gene, which encodes an aminoglycoside- and fluoroquinolone-modifying enzyme. Antimicrob Agents Chemother 50(9):3220-3221 (Pubitemid 44396445)
51. Bouchillon SK, Johnson BM, Hoban DJ, Johnson JL, Dowzicky MJ, Wu DH, Visalli MA, Bradford PA (2004) Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002. Int J Antimicrob Agents 24(2):119-124 (Pubitemid 38993689)
52. Forns N, Baños RC, Balsalobre C, Juárez A, Madrid C (2005) Temperature-dependent conjugative transfer of R27: role of chromosome- and plasmid-encoded Hha and H-NS proteins. J Bacteriol 187(12):3950-3959 (Pubitemid 40827778)
53. Grundmann H, Livermore DM, Giske CG, Cantón R, Rossolini GM, Campos J, Vatopoulos A, Gniadkowski M, Toth A, Pfeifer Y, Jarlier V, Carmeli Y; CNSE Working Group (2010) Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill 15(46):pii=19711